Skip to main content
. 2013 Jul 3;8(7):e69069. doi: 10.1371/journal.pone.0069069

Table 2. Severity of injury as indicated by histologic assessment to the extrahepatic biliary duct following injection with RRVa.

Days Post Infection Early Infection Late Infection
Day 3
Intraepithelial Inflammation 1 (0-1)b 0 (0-0)
Epithelial Damage 1 (0-2) 0 (0-0)
Edema 1 (0-2) 0.5 (0-1)
Submucosal Inflammation 1.5 (1-3) 1(1-1)
Stromal Proliferation 0 (0-0) 0 (0-0)
Total Injury 5 (4-8) 1.5 (1-2)
Day 5
Intraepithelial Inflammation 1 (0-1) 2 (1-2)
Epithelial Damage 1.5 (1-3) 2.5 (2-3)
Edema 1.5 (1-2) 1.5 (1-2)
Submucosal Inflammation 3 (1-3) 2 (2-3)
Stromal Proliferation 0 (0-0) 0 (0-0)
Total Injury 7 (7-9) 9 (8-11)
Day 7
Intraepithelial Inflammation 2 (1-4) 1 (1-2)
Epithelial Damage 2.5 (2-4) *c 1.5 (1-3)
Edema 2 (1-3)* 0 (0-0)
Submucosal Inflammation 2 (1-3) 2 (1-2)
Stromal Proliferation 1 (1-2) 0.5 (0-1)
Total Injury 10 (6-16)* 5 (3-7)
Day 12
Intraepithelial Inflammation 2 (1-3)* 0 (0-1)
Epithelial Damage 2 (1-3) 1 (1–1)
Edema 0 (0-3) 0 (0-0)
Submucosal Inflammation 2 (1-2) 0 (0-0)
Stromal Proliferation 1 (1-2)* 0 (0-0)
Total Injury 7 (4-13)* 2 (2-3)

a Severity of bile duct injury after inoculation with the RRV, as determined by histologic appearance of the extrahepatic biliary tract.

All sections were graded by a pathologist.

b Injury scoring is based on an ordinal scale from 0 to 4 Values are expressed as median scores, with ranges indicated in parentheses. The maximum total injury score possible was 20

c *p < 0.05 when compared with late infection.